SCHEMBL11892669

SCHEMBL11892669

CCCN(CCC)c1ccc2c(c1)Nc1cc(N(C)C)ccc1S2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRHR1 P34998 2/20 0.35
▸ NOX1 Q9Y5S8 10/20 0.35
▸ CYBB P04839 2/20 0.35
▸ NOX3 Q9HBY0 2/20 0.35
▸ NOX4 Q9NPH5 2/20 0.35
▸ AR P10275 1/20 0.35
▸ BCHE P06276 2/20 0.34
▸ ACHE P22303 2/20 0.34
▸ PSMB5 P28074 1/20 0.34
▸ MAPT P10636 5/20 0.33
▸ GAA P10253 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ ALOX15 P16050 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ SNCA P37840 3/20 0.33
▸ APP P05067 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11892660 0.91 TP53 (0.38) CRHR1NOX1CYBBNOX3NOX4
SCHEMBL5724694 0.88 MAPT (0.39) CRHR1NOX1ARBCHEACHE
SCHEMBL10476547 0.88 TERT (0.39) NOX1CYBBNOX3NOX4BCHE
SCHEMBL3026252 0.87 NOX1 (0.35) NOX1CYBBNOX3NOX4BCHE
Hydrochloric Acid SCHEMBL3035612 0.85 NOX1 (0.35) NOX1CYBBNOX3NOX4BCHE
SCHEMBL3035317 0.85 NOX1 (0.43) NOX1CYBBNOX3NOX4BCHE
SCHEMBL12592413 0.81 SNCA (0.43) NOX1ARBCHEACHEMAPT
SCHEMBL3645420 0.80 NOX1 (0.40) NOX1CYBBNOX3NOX4AR
SCHEMBL5724674 0.77 CNR2 (0.38) NOX1ARMAPTGAAMEN1
SCHEMBL3031840 0.77 NOX1 (0.31) NOX1CYBBNOX3NOX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067900-B2 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEVELOPMENT—P.H.D. (FR) 2015-06-30 — — US claimed
US-9067900-B2 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEVELOPMENT—P.H.D. (FR) 2015-06-30 — — US disclosed
US-9067900-B2 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEVELOPMENT—P.H.D. (FR) 2015-06-30 — — US disclosed
EP-2185531-B1 Diaminophenothiazine compounds, a method for preparing same and uses thereof PHARMA HYDRO DEV P H D (FR) 2012-07-25 — — EP disclosed
US-20100204215-A1 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2010-08-12 — — US disclosed
US-20100204215-A1 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2010-08-12 — — US disclosed
WO-2009044054-A2 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF PHARMA HYDRO DEVELOPMENT - P.H.D. (FR) 2009-04-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204215-A1 NOVEL DIAMINOPHENOTHIAZINE COMPOUNDS, A METHOD FOR PREPARING SAME AND USES THEREOF AOC1, DDT, DDC CRHR1 4840/4885NOX1 143/4885CYBB 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback